Trial intelligence / Profile preview

Dermal bioavailability of aluminium chlorohydrate antiperspirant in healthy women using a 26Al microtracer

NL-OMON40938Active, not recruiting

Sponsor
TNO
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of aluminium chlorohydrate and aluminum chloride (2 arms), sponsored by TNO. Primary endpoints: Adverse events, Local tolerability and 3 more. Started Aug 2014; status: active, not recruiting.

02

Drugs

aluminium chlorohydratealuminum chloride

Beyond the preview

Go deeper on NL-OMON40938.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON40938.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call